Unknown

Dataset Information

0

Nitroxide-HMP-Protects Human Trophoblast HTR-8/SVneo Cells from H2O2-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway.


ABSTRACT: Preeclampsia (PE) is a pregnancy-specific syndrome affecting 5-7% of patients. There is no effective treatment available. Early abnormal placental development is associated with oxidative stress (OS) and a release of reactive oxygen species (ROS) in the placenta. This phenomenon leads to downstream signaling, Hypoxia Inducible Factor 1A (HIF1A) stabilization and transcription of the anti-angiogenic factors soluble fms-like tyrosine kinase 1 (sFLT1) and soluble endoglin (sEng), which are known to cause endothelial and trophoblast dysfunction and cardinal features of PE: hypertension, proteinuria and, in severe cases, eclampsia. We tested whether 3-(Hydroxymethyl)-1-oxy-2,2,5,5-tetramethylpyrrolidine (HMP)-a nitroxide-type antioxidant molecule-can reduce placental OS and mitigate PE symptoms in vitro. We induced OS in human trophoblast (HTR-8/SVneo) cells with hydrogen peroxide (H2O2) and assessed whether modulating cell redox function with HMP reduces cell injury, mitochondrial stress and HIF1A and sFLT1 production. Pre-treatment with HMP reduced mitochondrial-derived ROS production, restored LC3B expression and reduced HIF1A and sFLT1 expression in H2O2-exposed HTR-8/SVneo trophoblast cells. HMP improved the mitochondrial electron chain enzyme activity, indicating that a reduction in OS alleviates mitochondrial stress and also reduces anti-angiogenic responses. In reducing placental trophoblast OS, HMP presents a potential novel therapeutic approach for the treatment of PE. Future investigation is warranted regarding the in vivo use of HMP.

SUBMITTER: Pintye D 

PROVIDER: S-EPMC10451835 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nitroxide-HMP-Protects Human Trophoblast HTR-8/SVneo Cells from H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway.

Pintye Diana D   Sziva Réka Eszter RE   Mastyugin Maxim M   Török Marianna M   Jacas Sonako S   Lo Agnes A   Salahuddin Saira S   Zsengellér Zsuzsanna K ZK  

Antioxidants (Basel, Switzerland) 20230808 8


Preeclampsia (PE) is a pregnancy-specific syndrome affecting 5-7% of patients. There is no effective treatment available. Early abnormal placental development is associated with oxidative stress (OS) and a release of reactive oxygen species (ROS) in the placenta. This phenomenon leads to downstream signaling, Hypoxia Inducible Factor 1A (HIF1A) stabilization and transcription of the anti-angiogenic factors soluble fms-like tyrosine kinase 1 (sFLT1) and soluble endoglin (sEng), which are known to  ...[more]

Similar Datasets

| S-EPMC10405378 | biostudies-literature
| S-EPMC5415790 | biostudies-literature
| S-EPMC7071057 | biostudies-literature
| S-EPMC3131303 | biostudies-literature
| S-EPMC9898646 | biostudies-literature
| S-EPMC9024043 | biostudies-literature
| S-EPMC11338994 | biostudies-literature
| S-EPMC7915079 | biostudies-literature
| S-EPMC11550733 | biostudies-literature
| S-EPMC1592099 | biostudies-literature